Partner Dan Shores will present on "Elevating the Expanding Patent Landscape for RNA-Based Therapeutics to Accelerate Approvals & Application" at the 2nd Next Generation RNA Therapeutics Summit taking place May 16-18, 2023, in Boston, Massachusetts.
Dan's session, being held on the first day of the conference, May 17, will help attendees gain insight into the trends an IP lawyer is seeing with respect to RNA payload and delivery innovations; provide an overview of the current competitive and IP landscape of next generation RNA therapeutics; address IP in the early stages of the discovery pipeline to set your candidate therapeutic up for success; and understand key steps to take before entering the preclinical stage from an IP perspective.
The 2nd Next Generation RNA Therapeutics Summit returns as the first and only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted, and efficacious, with reduced off targets than first generation RNA therapies to accelerate their therapeutic and commercial potential. Join 100+ thought leaders to stay ahead of the curve and maximize the full therapeutic potential of next generation RNA modalities to gain clinical proof concept and reach patients in need.
To learn more about the event, and to register, please visit the event website.